跳至主要内容
临床试验/NL-OMON25402
NL-OMON25402招募中不适用

Tumor-derived circulating endothelial cells as a biomarker in locally advanced and metastatic clear cell renal cell carcinoma

Erasmus MC Medical Center0 个研究点目标入组 75 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
75

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Patients with locally advanced or metastatic clear cell renal cell carcinoma
  • - Candidate for receiving first-line therapy with sunitinib or pazopanib

排除标准

  • - Serious illness or medical unstable condition prohibiting adequate treatment and follow-up
  • - Previous treatment with systemic therapy for clear cell renal cell carcinoma

研究者

发起方
Erasmus MC Medical Center

相似试验